SEARCH

SEARCH BY CITATION

References

  • 1
    Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med 1996;101(Suppl 1A):25S32S.
  • 2
    Stanton ME, Bright RM. Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review. J Vet Intern Med 1989;3:238244.
  • 3
    Wallace MS, Zawie DA, Garvey MS. Gastric ulceration in the dog secondary to the use of nonsteroidal antiinflammatory drugs. J Am Anim Hosp Assoc 1990;26:467472.
  • 4
    MacPhail C, Lappin M, Meyer D, et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc 1998;212:18951901.
  • 5
    Rubin SI, Papich MG. Clinical uses of nonsteroidal anti-inflammatory drugs in companion animal practice—Part II: Drugs, therapeutic uses and adverse effects. Canine Pract 1990;15:2733.
  • 6
    Tri-Med Specialties I. CLOtest: Diagnosis of Helicobacterpylori. Lenexa , KS : Delta West.
  • 7
    Johnston SA, Leib MS, Forrester SD, et al. The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs. J Vet Intern Med 1995;9:3238.
  • 8
    SAS/STAT User's Guide, 4th ed. Cary , NC : SAS Institute; 1990.
  • 9
    Stat Xact. Cambridge , MA : Cytel Software; 1992.
  • 10
    Eaton KA, Dewhirst FE, Paster BJ, et al. Prevalence and varieties of Helicobacter species in dogs from random source and pet dogs: Animal and public health implications. J Clin Microbiol 1996; 34:31653170.
  • 11
    Jenkins CC, Bassett JR. Helicobacter infection. Compend Contin Educ Pract Vet 1997;19:267279.
  • 12
    Hermanns W, Kregel K, Breuer W, et al. Helicobacter-liks organisms: Histopathological examination of gastric biopsies from dogs and cats. J Comp Pathol 1995;112:307318.
  • 13
    Happonen I, Saari S, Castren L, et al. Occurrence and topographical mapping of gastric Helicobacter like organisms and their association with histological changes in apparently healthy dogs and cats. J Vet Med A 1996;43:305315.
  • 14
    De Boer WA. Diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 1997;32(Suppl 223):3542.
  • 15
    Marshall BJ, Barrett LJ, Prakash C, et al. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990;99:697702.
  • 16
    Chen Y, Godil A, Wat P. Comparison of two rapid urease tests for detection of Helicobacter pylori infection. Dig Dis Sci 1998;43:16361640.
  • 17
    Pfizer. Rimadyl Technical Monograph. Exton , PA : Pfizer Animal Health; 1996.
  • 18
    Baruth H, Randall LO. Anti-inflammatory activity of the car-bazole, C-5720. Pharmacology 1974;33:557.
  • 19
    McKellar QA, Delatour P, Lees P. Stereospecific pharmacody-namics and pharmacokinetics of carprofen in the dog. J Vet Pharmacol Therap 1994;17:447454.
  • 20
    MacPhail C, Lappin M, Meyer D, et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc 1998;212:1895901.
  • 21
    Kraml M, Cosyns L, Hicks DR. Bioavailability studies of etodolac in dogs and man. Biopharm Drug Disp 1984;5:6374.
  • 22
    Honda K, Nakamura A, Murino A, et al. Studies of the metabolic fate of etodolac. Absorption, distribution, and excretion in mice, rats, and dogs after single administration. Iyakuhin Kenkyu 1991;22:109123.
  • 23
    Cayen M, Kraml M, Gerdinandi E, et al. The metabolic disposition of etodolac in rats, dogs, and man. Drug Metab Rev 1981; 12:339.
  • 24
    Laneuville O, Breuer DK, Dewitt D, et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994; 271:927934.
  • 25
    Glaser K, Sung ML, O'Neill K, et al. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995;281:107111.
  • 26
    Lanza FL, Graham DY, Davis RE, et al. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen induced acute gastroduodenal injury: Effect of scoring method. Dig Dis Sci 1990; 35:14941499.
  • 27
    Lanza FL. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 1993;88:13181323.
  • 28
    Budsberg S, Johnston S, Schwartz P, et al. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. J Am Vet Med Assoc 1999;214:206210.
  • 29
    Johnston SA, Budsberg SC. Nonsteroidal anti-inflammatory drugs and corticosteroids for the management of canine osteoarthritis. Vet Clin North Am (Small Anim Pract) 1997;27:841862.
  • 30
    Konturek SW, Piastucki I, Brozozowski T, et al. Role of pros-taglandins in the formation of aspirin-induced gastric ulcers. Gastro-enterology 1981;80:49.
  • 31
    Lipowitz A, Boulay J, Klausner J. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products. Am J Vet Res 1986; 47:15861589.
  • 32
    Boulay JP, Lipowitz AJ, Klausner JS. Effect of cimetidine on aspirin-induced gastric hemorrhage in dogs. Am J Vet Res 1986;47:17441746.
  • 33
    Forsythe SF, Guilford WG, Lawoko CRO. Endoscopic evaluation of the gastroduodenal mucosa following non-steroidal anti-inflammatory drug administration in the dog. NZ Vet J 1996;44:179181.
  • 34
    Miller TA. Gastroduodenal mucosal defense: Factors responsible for the ability of the stomach and duodenum to resist injury. Surgery 1988;103:389397.
  • 35
    Fox SM, Johnston SA. Use of carprofen for the treatment of pain and inflammation in dogs. J Am Vet Med Assoc 1997;210:14931498.
  • 36
    Vane JR, Botting RM. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). Adv Prostaglandin Thromboxane Leukotriene Res 1995;23:4154.
  • 37
    Akarasereenont P, Mitchell JA, Thiemermann C, et al. Relative potency of nonsteroidal antiinflammatory drugs as inhibitors of cyclo-oxygenase-1 or cyclooxygenase-2. Br J Pharmacol 1994; 122 (Suppl): 183 P.
  • 38
    Dvornik DM. Tissue selective inhibition of prostaglandin biosynthesis by etodolac. J Rheumatol 1997;24:4047.
  • 39
    Ricketts A, Lundy K, Seibel S. Evaluation of selective inhibitors of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 1998;59:14411446.
  • 40
    Wallace JL. Nonsteroidal anti-inflammatory drugs and gastro-enteropathy: The second hundred years. Gastroenterology 1997;112:10001016.
  • 41
    Pearson SP, Kelberman I. Gastrointestinal effects of NSAIDs: Difficulties in detection and management. Postgrad Med 1996;100:131143.
  • 42
    Otte V, Small D, Rice D, et al. Aspirin dosage for canine osteoarthritis. Vet Forum 1996: 4244.
  • 43
    Marks S, Melli A, Kass P, et al. Critical appraisal of methods to diagnose Clostridium perfringens-associated diarrhea. J Vet Intern Med 1998; 12:204.
  • 44
    Lanas A, Serrano P, Bajador E, et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997;112:683689.
  • 45
    Stamm C, Burkhalter E, Pearce W, et al. Benign colonic ulcers associated with nonsteroidal antiinflammatory drug ingestion. Am J Gastroenterol 1994;89:22302233.
  • 46
    Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs: Report of 4 cases and review of the literature. Arch Intern Med 1992;152:625632.
  • 47
    Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995;38:13111321.
  • 48
    Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513516.